PADH2: Seated - Standing Passage of the Hemiplegic

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03117699
Collaborator
(none)
45
2
2
12
22.5
1.9

Study Details

Study Description

Brief Summary

This is a study for a new mechanical transport device adapted to the hemiplegic patients.

Healthy volunteers :

After explaining the protocol and presenting the movement laboratory, the subjects are equipped with reflective markers on the 4 limbs, the trunk and the head. The subjects are installed on a seat positioned in front of 2 force platforms installed on the ground. The seat is equipped with a force platform.

Phase 1 :
After being seated, the subject realizes :
  • 3 seat to stand and stand to seat without assistance

  • 3 seat to stand and stand to seat using a handle located in front of it (handle equipped with a 6-axis force sensor)

  • 3 seat to stand and stand to seat using the experimental device This phase will last 45minutes (mn) (30mn of equipment and 15mn of sitting passengers standing)

Phase 2:
After being seated, the subject performs a course comprising:
  • A standing pass from sitting on a chair

  • A straight line movement

  • A succession of left and right turns

  • An upward and downward travel of less than 1%.

  • Standard doorway

  • Standing on the toilet

  • A sitting pass from the toilet

  • One way to a bed

  • A sitting pass on the bed

  • A passenger seat sitting upright from the bed

  • A return to the starting point

  • A sitting pass on the starting chair Each stage is timed. A subjective analysis of each step is done by a lickert scale on the perceived comfort and safety.

This phase 2 will last 30mn (15mn of course and 15mn of questions).

Hemiplegic subjects :

At each session, the subject is examined by a physician who evaluates the motor control (Fugl Meyer scale), the equilibrium (Berg scale) and the spatial hemineglect (Bergego scale).

Phase 1 is performed except the 3 seat to stand and stand to seat without assistance which are impossible.

Phase 2 is performed. An evaluation of the device over 4 hours is carried out for each subject in therapeutic apartment in simulated living conditions. The validation in living lab is carried out by an ergonomist and by a questionnaire on the comfort and safety of the various steps identified by the ergonomist.

Condition or Disease Intervention/Treatment Phase
  • Device: New device for seated-standing passages
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Continuation of the Exploration of the Standing Seated Passage of the Hemiplegic for the Realization of a New Transport Device
Actual Study Start Date :
Apr 13, 2017
Actual Primary Completion Date :
Apr 13, 2018
Actual Study Completion Date :
Apr 13, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hemiplegic subjects

Testing of a new device for seated-standing passages after undergoing medical evaluation included Fugl Meyer scale, Berg scale and Bergego scale. Phase 1 : 3 seated-standing passages with a handle equipped with 6 force captors 3 seated-standing passages with the device

Device: New device for seated-standing passages
Phase 1 : The subject perform different seated-standing passages (see "Arm") Phase 2 : After being seated, the subject performs a course comprising: A standing pass from sitting on a chair A straight line movement A succession of left and right turns An upward and downward travel of less than 1%. Standard doorway Standing on the toilet A sitting pass from the toilet One way to a bed A sitting pass on the bed A passenger seat sitting upright from the bed A return to the starting point A sitting pass on the starting chair

Experimental: Healthy volunteers

Testing of a new device for seated-standing passages . Phase 1 : 3 seated-standing passages without help 3 seated-standing passages with a handle equipped with 6 force captors 3 seated-standing passages with the device

Device: New device for seated-standing passages
Phase 1 : The subject perform different seated-standing passages (see "Arm") Phase 2 : After being seated, the subject performs a course comprising: A standing pass from sitting on a chair A straight line movement A succession of left and right turns An upward and downward travel of less than 1%. Standard doorway Standing on the toilet A sitting pass from the toilet One way to a bed A sitting pass on the bed A passenger seat sitting upright from the bed A return to the starting point A sitting pass on the starting chair

Outcome Measures

Primary Outcome Measures

  1. Time required to carry out each step of use of the device [Day 1]

    Each step of phase 1 and phase 2 will be timed.

Secondary Outcome Measures

  1. Record of all adverse reactions. [Day 1]

    The safety of the devices will be evaluated by the occurrence of adverse reactions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Healthy volunteers :
  • aged 18-75 years

  • Subject having given his consent

  • Free from any neurological or cardiorespiratory locomotor pathology that may interfere with standing seated passages.

Hemiplegic patients :
  • Left hemiplegia in one of the following groups :

  • Walking with difficulty or not walking and able to stand with a stick or an armrest

  • Walking difficult or not walking and unable to stand with a cane or an armrest.

  • aged 18-90 years

  • Subject having given his consent

  • Subjects with a trunk balance to sit without support

Exclusion Criteria:
  • aged less than 18 or more than 75 (healthy volunteers) or more than 90 (hemiplegic subjects)

  • Pain during seated-standing passages

  • Unstable medical condition

  • Unable to consent

  • Subject under legal protection

  • Left-hemineglect making standing or seated (wheelchair) displacements impossible autonomously (for hemiplegic patients)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brest University Hospital Brest France 29200
2 Centre de rééducation fonctionnelle de KERPAPE Ploemeur France 56000

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT03117699
Other Study ID Numbers:
  • 29BRC16.0012 PADH2
First Posted:
Apr 18, 2017
Last Update Posted:
Mar 4, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Brest
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 4, 2022